Clinical characteristics and outcomes of COVID-19 patients in a tertiary hospital in Baguio City, Philippines
Karen Joyce Cortez, Bernard A Demot, Samantha S Bartolo, Dexter D Feliciano, Verna Moila Ciriaco, Imari Irish Labi, Denzelle Diane Viray, Jenna Charise Casuga, Karol Anne Camonayan-Flor, Precious Mae Gomez, Marie Ellaine Velasquez, Thea Pamela Cajulao, Jovy E Nigos, Maria Lowella De Leon, Domingo P Solimen, Angelita G Go, Francis M Pizarro, Larry C Haya Jr, Ray P Aswat, Virginia B Mangati, Caesar Noel Palaganas, Mylene N Genuino, Kimberley M Cutiyog-Ubando, Karen C Tadeo, Marinelle Longid, Nowell Benedict Catbagan, Joel B Bongotan, Beverly Anne Dominguez-Villar, Joeffrey B Dalao
Western Pacific Surveillance and Response Journal, doi:10.5365/wpsar.2021.12.4.852
oronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), primarily targets the respiratory system. In December 2019, an epidemiological alert was released in China following a rise in cases of pneumonia of unknown cause. The Philippines announced its first confirmed case on 31 January 2020. 1,2 The World Health Organization (WHO) officially declared a global pandemic on 11 March 2020, by which time the Philippines already had 49 confirmed cases, largely in the National Capital Region. 2 Baguio City is located north of Manila, within the Cordillera Central mountain range in northern Luzon. The estimated population is 345 000, with adults (aged 19-60 years) and those aged over 60 years comprising 52% and 6.6% of the population, respectively. 3 Leading causes of morbidity include hypertension, diabetes, bronchitis and asthma. 4 The first confirmed case in Baguio City was recorded on the city's ninth day of quarantine during March 2020, with local sustained transmission declared six months later. 5 Worldwide, by the end of October 2020, there were 43 623 111 confirmed cases and 1 161 311 deaths. At that time in the Philippines, cases had risen
Conflicts of interest The authors declare no conflicts of interest.
Ethics approval This study has been approved by the Ethics Review Board of Baguio General Hospital and Medical Center, Baguio City, Philippines.
References
Adapa, Chenna, Balla, Merugu, Koduri et al., COVID-19 pandemic causing acute kidney injury and impact on patients with chronic kidney disease and renal transplantation, J Clin Med Res,
doi:10.14740/jocmr4200pmid:32587651
Catajan, COVID-19 clusters in Baguio
Council, Eracoda, Group, Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA, Nephrol Dial Transplant,
doi:10.1093/ndt/gfaa314pmid:33340043
Henry, Aggarwal, Wong, Benoit, Vikse et al., Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: a pooled analysis, Am J Emerg Med,
doi:10.1016/j.ajem.2020.05.073pmid:32738466
Long, Nie, Xiang, Li, Zhang et al., D-Dimer and prothrombin time are the significant indicators of severe COVID-19 and poor prognosis, BioMed Res Int,
doi:10.1155/2020/6159720pmid:32596339
Marcon, Tettamanti, Capacci, Fontanel, Spanò et al., COVID-19 mortality in Lombardy: the vulnerability of the oldest old and the resilience of male centenarians, Aging (Albany NY),
doi:10.18632/aging.103872pmid:32788424
Mesas, Cavero-Redondo, Álvarez-Bueno, Cabrera, De Andrade et al., Predictors of inhospital COVID-19 mortality: a comprehensive systematic review and meta-analysis exploring differences by age, sex and health conditions, PLoS One,
doi:10.1371/journal.pone.0241742pmid:33141836
Simadibrata, Calvin, Wijaya, Ibrahim, Neutrophil-to-lymphocyte ratio on admission to predict the severity and mortality of COVID-19 patients: A meta-analysis, Am J Emerg Med,
doi:10.1016/j.ajem.2021.01.006pmid:33453617
Soria, Macalalad-Josue, Quiwa, Duya, Calvario et al., Clinical profile and outcomes of hospitalized patients with COVID-19 in the Philippines: a preliminary report
Yan, Faraji, Prajapati, Ostrander, Deconde, Selfreported olfactory loss associates with outpatient clinical course in COVID-19, Int Forum Allergy Rhinol,
doi:10.1002/alr.22592pmid:32329222